TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · IEX Real-Time Price · USD
92.08
+2.83 (3.17%)
At close: Apr 26, 2024, 4:00 PM
92.12
+0.04 (0.04%)
After-hours: Apr 26, 2024, 7:51 PM EDT

TransMedics Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017
Market Capitalization
3,0122,5771,970532541393--
Market Cap Growth
-30.78%270.34%-1.57%37.38%---
Enterprise Value
3,1332,6981,83648344934613-17
PE Ratio
-102.96-102.96-54.38-12.03-18.80-11.73--
PS Ratio
12.4710.6721.0817.5821.0816.67--
PB Ratio
21.9618.7810.527.845.207.20--
P/FCF Ratio
-15.63-15.63-34.13-16.43-17.59-12.12--
P/OCF Ratio
-197.80-197.80-43.01-18.43-17.86-12.19--
EV/Sales Ratio
12.9711.1619.6515.9617.5114.680.99-2.15
EV/EBITDA Ratio
-404.91-404.91-65.01-12.82-19.39-12.40-0.640.86
EV/EBIT Ratio
-169.87-169.87-56.61-11.98-18.16-11.88-0.620.84
EV/FCF Ratio
-16.36-16.36-31.81-14.91-14.62-10.67-0.490.71
Debt / Equity Ratio
3.763.760.360.650.330.62-0.18-0.05
Debt / EBITDA Ratio
-77.45-77.45-2.39-1.16-1.50-1.22-1.66-0.45
Debt / FCF Ratio
-3.13-3.13-1.17-1.35-1.13-1.05-1.28-0.37
Quick Ratio
8.358.359.694.2611.205.451.932.39
Current Ratio
9.309.3010.665.1112.366.212.773.12
Asset Turnover
0.410.410.470.220.180.250.33-
Interest Coverage
-1.47-1.47-8.71-10.40-6.21-6.70-7.72-18.39
Return on Equity (ROE)
-16.60%-16.60%-29.80%-53.10%-30.80%1375.40%13.20%-
Return on Assets (ROA)
-4.20%-4.20%-18.30%-32.00%-20.10%-35.50%-60.00%-
Return on Capital (ROIC)
-4.40%-4.40%-12.33%-35.31%-19.04%-33.34%12.76%12.76%
Earnings Yield
-0.83%-0.97%-1.84%-8.31%-5.32%-8.53%--
FCF Yield
-5.47%-6.40%-2.93%-6.09%-5.68%-8.25%--
Buyback Yield / Dilution
-10.02%-10.02%-7.02%-11.80%-73.90%-945.47%70.77%-3.23%
Total Shareholder Return
-10.02%-10.02%-7.02%-11.80%-73.90%-945.47%70.77%-3.23%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).